baber/WOPTO huggingface dataset:
Patent AU-2021264421-A1 (AU)
Title: Compounds and methods targeting interleukin-34
Inventor: CHEDID MARCIO
IPC: C07K16/24
Filed: 2021-04-23
Abstract: The present invention relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.
Patent AU-2021267695-A1 (AU)
Title: Pharmaceutical combination comprising a brain aminopeptidase A inhibitor, a diuretic and a blocker of the systemic renin-angiotensin system
Inventor: BALAVOINE FABRICE
IPC: A61P9/00
Filed: 2021-05-05
Abstract: The present invention relates to a pharmaceutical combination comprising (i) firibastat, (ii) a diuretic and (iii) a blocker of the systemic renin-angiotensin system selected from the group consisting of angiotensin I converting enzyme inhibitors (ACEIs) and angiotensin II receptor type 1 (AT1R) antagonists. Said composition is particularly useful for the treatment of hypertension and related diseases and conditions.
Patent AU-2021278108-A1 (AU)
Title: Multi-radio synchronization within a single connected system
Inventor: HANLEY JAMES PATRICK
IPC: H04B1/7156
Filed: 2021-05-14
Abstract: A multi-radio border router for synchronizing communications of multiple border router radios is provided. For example, the border router includes a border router component connected to each of the plurality of border router radios. The border router component configured for selecting one of the plurality of border router radios as a master radio and assigning channel offset parameters for each of the plurality of border router radios. The master radio is configured for broadcasting synchronization beacons based on which the non-master radios synchronize their respective clocks with that of the master radio. After the synchronization, each of the border router radios communicates with endpoints associated therewith according to a channel hopping pattern modified by applying a channel offset determined based on the channel offset parameters assigned to the respective radio.
Patent AU-2021280374-A1 (AU)
Title: Scraper sponge
Inventor: OMOTOLA ALAHANDRO O
IPC: A47L13/12
Filed: 2021-06-22
Abstract: A scraper sponge for cleaning and scraping away unwanted substances from an object or surface comprising a sponge body defining a first surface, first layer, second layer, third layer, second surface opposite the first surface, a continuous side surface around the perimeter; and the back of a scraper attachment that is inserted through an aperture in layers two and three rests firmly against the first layer where it borders the second layer and a smaller cylinder shaped part on the back of the scraper attachment is inserted through a smaller aperture approximately through the middle of the first layer and first surface and held in place by a scraper cap and fixedly secured with adhesive. The entire front surface area of the scraper is covered with pyramid shaped points extending outwardly in the direction of the second surface and is made level with the second surface when forces are applied to the top surface of the scraper cap and subsequent back of scraper attachment to manipulate the rigid scraper on a hard surface.
Patent AU-2021306432-A1 (AU)
Title: Solar powered water desalinator and method
Inventor: PETRISCA DARIAN
IPC: C02F1/14
Filed: 2021-07-09
Abstract: A water desalinator that employs the use of solar concentration, evaporation and humidification, mimicking the natural hydrological cycle in a closed, modular vessel to produce freshwater from salt, brackish, brines and seawater, and a concentrate stream for further processing. Feed water is received and stored in a basin. Surface humidity is generated by the evaporation of basin water. A lens is used to focus sunlight, tracked the suns path based on biomimicry of a sunflower, on a thermal conductor. The thermal conductor has a rounded side-profile and generates a variable temperature across its radius. Water is pumped from the basin to a sprinkler head to be dripped or sprayed on the thermal conductor to generate water vapour. This water vapour consequently mixes with the air in the reaction vessel to increase system humidity. Humid air is removed from the reaction vessel and condensed in a condenser. Accordingly, the salinity concentration of input water is reduced from the output of the reaction vessel. Multiple reaction vessels or concentrators may be used in tandem to achieve improved performance.
Patent AU-2021358957-A1 (AU)
Title: Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21
Inventor: CHILDERS MARTIN K
IPC: A61K48/00
Filed: 2021-10-06
Abstract: Disclosed herein are various optimized nucleic acids encoding the fukutin-related protein (FKRP). Recombinant vectors comprising the optimized nucleic acid (e.g. operatively linked to a muscle specific promoter), such as recombinant adeno-associated virus vectors, for expressing the protein (e.g. in skeletal and cardiac muscle), and therapeutic compositions contains the vectors are also disclosed. Therapeutic methods of administration of the vectors to a subject for the treatment of a subject with a dystroglycanopathy disorder (e.g., limb-girdle muscular dystrophy 2I) are also disclosed.
Patent AU-2021376188-A1 (AU)
Title: Cxcr1/cxcr2 inhibitors for use in treating myelofibrosis
Inventor: HOFFMAN RONALD
IPC: A61P35/00
Filed: 2021-11-04
Abstract: Provided herein are compositions comprising CXCR1/CXCR2 inhibitors as well as methods of using the CXCR1/CXCR2 inhibitors disclosed herein. In embodiments, provided are methods of treating myelofibrosis, methods of decreasing bone marrow fibrosis, methods of reducing the interaction of IL-8 to CXCR1 and/or CXCR2, and methods of reducing the activity or and/or signaling through CXCR1 and/or CXCR by administering to a subject in need thereof an effective amount of a CXCR1/CXCR2 inhibitor disclosed herein.
Patent AU-2021401580-A1 (AU)
Title: Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders
Inventor: CHEN XIN
IPC: A61P35/00
Filed: 2021-12-13
Abstract: The present application relates to treating and/or preventing breast cancer, including locally advanced or metastatic, ER+, HER2- breast cancer, in a subject in need of treatment, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt, enantiomer, stereoisomer, solvate, polymorph, isotopic derivative, or prodrug thereof, wherein R
Patent AU-2021409859-A1 (AU)
Title: Transaction data processing systems and methods
Inventor: CHEAH SOON-EE
IPC: G06E1/00
Filed: 2021-08-25
Abstract: Described embodiments relate to determining a candidate financial record associated with a transaction between a first accounting entity and a second entity, and determining, using a numerical representation generation model, a numerical representation of the candidate financial record, the numerical representation generation model having been trained on a corpus generated from historical transaction records. The method further comprises providing, to a transaction attribute prediction model, the numerical representation of the candidate financial record, the transaction attribute prediction model having been trained using a dataset of previously reconciled financial records, each associated with a respective first transaction attribute; and determining, by the transaction attribute prediction model, at least one first transaction attribute associated with the candidate financial record.
Patent AU-2022200386-A1 (AU)
Title: System for use of retirement funds for investment and disbursement
Inventor: JONES SIMON PETER
IPC: G06Q50/16
Filed: 2022-01-20
Abstract: An electronic management system comprising of digital processors, 
database storage medium and input and output devices; said system 
executing software steps in the management of transactions between 
financial entities; said financial entities including at least an 
owner/s of a property (prospective or actual),a retirement fund of 
said owner/s and an associated managed fund; said transactions 
including application by said owner/s for an acquisition by said 
managed fund of investment equity in said owner/s' property.
Patent AU-2022200456-A1 (AU)
Title: Dual pawl ratchet mechanism
Inventor: ROSS DAVID T
IPC: B25B17/02
Filed: 2022-01-25
Abstract: A ratchet mechanism of a ratchet wrench having a pawl carrier and first and second 
pawls. The pawl carrier includes a groove and is rotatable to cause selection of one of first 
and second drive directions. The first and second pawls are adapted to selectively engage 
with a toothed portion of a ratchet gear for selecting one of the first and second drive 
directions. Each of the first and second pawls includes a projection adapted to engage the 
groove when the pawl carrier is rotated to cause one of the first and second pawls to 
disengage from the toothed portion and the other of the first and second pawls to engage the 
toothed portion.  
18419853_1 (GHMatter) P118120.AU
1/10 
100 
152 
106 
102 126 
12 112 132 
128 140 
122 3 134 
14248 
1242 
-4FIG 15
Patent AU-2022202261-A1 (AU)
Title: User interfaces for enabling an activity
Inventor: ZHANG YONGJUN
IPC: G06F9/451
Filed: 2022-04-05
Abstract: The present disclosure generally relates to user interfaces for enabling an activity using a 
computer system. In some embodiments, exemplary user interfaces for invoking an activity 
associated with an application are described. In some embodiments, exemplary user interfaces 
for customizing displayed content based on circumstances under which the content was invoked 
are described. In some embodiments, exemplary user interfaces for managing applications that 
were used to enable activities are described. In some embodiments, exemplary user interfaces 
for managing settings for applications used to enable activities are described.
Patent AU-2022204322-A1 (AU)
Title: Alkaline oxidation process and device for treating refractory sulfide ore, in particular refractory gold ore
Inventor: DU PLESSIS CHRIS
IPC: B02C17/00
Filed: 2022-06-20
Abstract: ALKALINE OXIDATION PROCESS AND DEVICE FOR TREATING REFRACTORY 
SULFIDE ORE, IN PARTICULAR REFRACTORY GOLD ORE 
Alkaline oxidation device for treating refractory sulfide ore or 
concentrate particles enriched in a metal to be recovered comprising stages in 
which refractory ore or concentrate particles are surface-oxidized in agitated 
5 reactors for forming an alkaline slurry by alkaline oxidation in lime liquid phase , 
which slurry is thereafter mechanically activated in mechanical activation 
means to remove passivating coatings from the surface oxidized refractory ore 
particles.  
FIG 2
1/2 
Fig.1 5 
CT)n (MA) n 
2 
Fig.2 
MA1 MA2 MA3 MA4 MA5 MA6 
CSTR1 CSTR2 CSTR3 CSTR4 CSTR5 CSTR6 
Fig.3 
MA1 MA2 MA3 MA4 MA5 MA6 
CSTR1 CSTR2 CSTR3 CSTR4 CSTR5 CSTR6 
Fig.4 
MA1 MA2 MA3 MA4 MA5 MA6 
CSTR1 CSTR2 CSTR3 CSTR4 CSTR5 CSTR6
Patent AU-2022218787-A1 (AU)
Title: INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS
Inventor: LOWERY ROBERT
IPC: A61K31/4709
Filed: 2022-02-11
Abstract: This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating or preventing inappropriate activation of a type I interferon (IFN) response in a subject in need thereof.
Patent AU-2022232311-A1 (AU)
Title: Use of nadolol to treat chronic obstructive pulmonary disease by blockage of the arrestin-2 pathway
Inventor: GLASS MITCHELL
IPC: A61P11/06
Filed: 2022-03-08
Abstract: The present invention is directed to compositions and methods for treating chronic obstructive pulmonary disease (COPD) and other diseases and conditions affecting the respiratory tract through inhibition of the β-arrestin (arrestin-2) pathway by use of β-adrenergic inverse agonists, particularly including nadolol. The compositions and methods can be used to treat pulmonary symptoms associated with infection with SARS-CoV-2.
Patent AU-2022257285-A1 (AU)
Title: Process for producing 1,1-gpm- and/or 1,6-gps-enriched isomalt compositions
Inventor: BOETTGER CHRISTOPH
IPC: A23L27/30
Filed: 2022-04-13
Abstract: The present invention relates to a process for producing isomalt compositions enriched in 1-O-α-D-glucopyranosyl-D-mannitol (hereinafter 1,1-GPM) and/or in 6-O-α-D-glucopyranosyl-D-sorbitol (hereinafter 1,6-GPS) from isomalt-containing solutions, these being solutions containing hydrogenated isomaltulose, to 1,1-GPM- and/or 1,6-GPS-enriched isomalt compositions produced by the process of the invention, and to the use of these 1,1-GPM- and/or 1,6-GPS-enriched isomalt compositions.
Patent AU-2022285767-A1 (AU)
Title: Systems and methods for manufacturing api-containing edibles, and resulting edible products
Inventor: WARREN WILLIAM
IPC: A23G3/36
Filed: 2022-06-06
Abstract: This present disclosure provides reliable methods and apparatus for delivering a pharmaceutical active ingredient to a food product that is produced in a batch process. In one example, the active pharmaceutical ingredient is added after the batch food product has been cooked and cooled. The food product can be a candy, a baked good, or any alternative food product that is mixed as a batch and subsequently cooked and cooled.
Patent AU-2022308487-A1 (AU)
Title: Leaning-vehicle-traveling-data-processing device
Inventor: MORISHIMA KEISUKE
IPC: B60W40/09
Filed: 2022-06-30
Abstract: Provided is a lean vehicle travel data processing device which can increase the degree of freedom of design of a hardware resource, while increasing the accuracy of economic loss-related data obtained on the basis of lean vehicle travel data. The lean vehicle travel data processing device 1 comprises a memory 20, and a processor 10. The processor 10 generates and outputs economic loss-related data on the basis of lean vehicle travel data stored in the memory 20 by using an economic loss-related data generation model. The economic loss-related data generation model is configured to generate the economic loss-related data in response to sudden movements tilted in the lateral directions of a vehicle body on the basis of data, which indicates movements tilted in the lateral directions of the vehicle body, included in the lean vehicle travel data so that first economic loss-related data generated on the basis of first lean vehicle travel data is different from second economic loss-related data generated on the basis of second lean vehicle travel data.
Patent AU-2022320193-A1 (AU)
Title: A mountable rack and kit for a motor vehicle and a method of mounting a rack for a motor vehicle
Inventor: BEDARD GUILLAUME
IPC: B60R9/10
Filed: 2022-07-20
Abstract: A mountable bicycle, motorcycle or all-terrain vehicle rack for a motor vehicle having a connector mount operable to connect to the motor vehicle, a pivot arm having distal and proximal ends, the proximal end pivotably connected to the connector mount and an actuator connected to the connecter mount and to the pivot arm and operable to actuate the pivot arm between a lowered position and a raised lowered position relative to the connector mount. The actuator may be configured to be electrically connected to an electric source. The rack additionally includes first securing means adjacent the distal end of the pivot arm to secure a first end of the bicycle, motorcycle or all-terrain vehicle to the pivot arm and second securing means adjacent the proximal end of the pivot arm to secure a second end of the bicycle, motorcycle or all-terrain vehicle to the pivot arm.
Patent AU-2022375806-A1 (AU)
Title: Lag-3 antagonist therapy for hematological cancer
Inventor: SRIVASTAVA SHIVANI
IPC: C07K16/28
Filed: 2022-10-28
Abstract: The disclosure provides a method of treating a human subject afflicted with a hematological cancer with a lymphocyte activation gene-3 (LAG-3) antagonist. In some aspects, the method comprises combination of the LAG-3 antagonist with an additional therapeutic agent
Patent AU-2023200807-A1 (AU)
Title: Oligonucleotide compositions and methods thereof
Inventor: VARGEESE CHANDRA
IPC: A61K48/00
Filed: 2023-02-14
Abstract: Among other things, the present disclosure relates to chirally controlled 
oligonucleotides of select designs, chirally controlled oligonucleotide compositions, and 
methods of making and using the same. In some embodiments, a provided chirally controlled 
oligonucleotide composition provides different cleavage patterns of a nucleic acid polymer 
than a reference oligonucleotide composition. In some embodiments, a provided chirally 
controlled oligonucleotide composition provides single site cleavage within a complementary 
sequence of a nucleic acid polymer. In some embodiments, a chirally controlled 
oligonucleotide composition has any sequence of bases, and/or pattern or base modifications, 
sugar modifications, backbone modifications and/or stereochemistry, or combination of these 
elements, described herein.
Patent AU-2023201681-A1 (AU)
Title: Blood pump
Inventor: SIESS THORSTEN
IPC: A61M60/122
Filed: 2023-03-17
Abstract: Blood pump (50) for percutaneous insertion into a heart's ventricle comprising an electrical 
motor (51) for driving the blood pump (50), the electrical motor (51; 51-2) comprising at least 
three motor winding units (Lu, Lv, Lw), wherein each motor winding unit (Lu, Lv, Lw) is indi
5 vidually connectable to a power supply (110) via two separate phase supply lines (Lu1, Lu2; 
Lv1, Lv2; Lwl, Lw2) connected to the respective motor winding unit terminals (LuE1, LuE2; 
LvE1, LvE2; LwE1, LwE2). Motor controller (100) for driving and controlling the electrical mo
tor (51; 51-2) of the blood pump (50), wherein the motor controller comprises corresponding 
phase supply line driving units (DH1, DH2, DH3; DL1, DL2, DL3) for each motor winding 
) units (Lu, Lv, Lw) of the electrical motor (51; 51-2) of the blood pump (50) which phase sup
ply line driving units (DH1, DH2, DH3; DL1, DL2, DL3) are connected via the corresponding 
two phase supply lines (Lu1, Lu2; Lv1, Lv2; Lw, Lw2) with the corresponding motor winding 
unit (Lu, Lv, Lw). Blood pump system comprising the blood pump (50) and the motor control
ler (100). Control method for controlling the power supply to the motor winding units (Lu, Lv, 
5 Lw) of the blood pump (50), wherein the method comprises: detecting a fault of one of the 
motor winding units (Lu, Lv, Lw), and in case of a detected faulty motor winding unit, switch
ing off the corresponding phase supply line driving unit (DH1, DH2, DH3; DL1, DL2, DL3) of 
the faulty motor winding unit and further operating the electrical motor (51; 51-2) by the re
maining motor winding units (Lu, Lv, Lw), or, alternatively, adjusting driving parameters of the 
) faulty motor winding unit and further operating the electrical motor by all motor winding units 
(Lu, Lv, Lw). Use of at least three independent motor winding units (Lu, Lv, Lw) in an electri
cal motor (51; 51-2) for driving of a blood pump (50) for percutaneous insertion, which motor 
winding units (Lu, Lv, Lw) are individually connected to corresponding power supply (110) via 
corresponding two separate phase supply lines (Lul, Lu2; Lv1, Lv2; Lwl, Lw2) connected to 
5 respective motor winding unit terminals (LuE1, LuE2; LvE1, LvE2; LwE1, LwE2) of one of the 
at least three motor winding units (Lu, Lv, Lw).  
(Figure 1)
1/3 
585 
Fig. I 
LwEl L E2 
Lw Lu Lj uL 
LW Lv LwE2 LE 
LvE2 IvEl 
Lv 
Fig. 2 (a) (b) (C)
Patent AU-2023202299-A1 (AU)
Title: A method of gaming, a gaming system and a game controller
Inventor: NGUYEN HUNG NGOC
IPC: G07F17/34
Filed: 2023-04-14
Abstract: A method of gaming comprising: selecting in at least one game round a plurality of symbols for 
display to a player in a set of display positions; modifying the displayed symbols copying each 
5 symbol in an original subset of the display positions to at least one clone subset of the display 
positions which is identical to or laterally displaced from the original subset, in response to 
determining that a subset of the symbols should be cloned; and determining an outcome 
based on the modified symbols.
Patent AU-2024200136-A1 (AU)
Title: Pyrazolopyrimidine compounds as adenosine receptor antagonists
Inventor: BELL ANDREW SIMON
IPC: C07D487/04
Filed: 2024-01-09
Abstract: The invention provides a compound of formula (I), or pharmaceutically acceptable ester, 
amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or 
carbamate, 
5 
NH2 
N 
RN N 
(1) 
wherein R' is an optionally substituted phenyl, or an optionally substituted 5- or 6
membered aromatic heterocycle comprising 1, 2 or 3 heteroatoms independently selected 
10 from the group consisting of N, S and 0, wherein said phenyl is optionally substituted with 1, 
2 or 3 substituents, each substituent being independently selected from the group 
consisting of halogen, OH, C1.salkyl, C1.alkyl substituted with 1, 2 or 3 halogens or OH 
groups, OCi-8alkyl, and OC1.salkyl substituted with 1, 2 or 3 halogens or OH groups, and 
wherein said 5- or 6-membered aromatic heterocycle is optionally substituted with 1, 2 or 3 
15 substituents, each substituent being independently selected from the group consisting of 
halogen, OH, C1.salkyl, C1.salkyl substituted with 1, 2 or 3 halogens or OH groups, OC1.8alkyl, 
and OC1.8alkyl substituted with 1, 2 or 3 halogens or OH groups; and 
R 2 s an optionally substituted 5- or 6-membered aromatic heterocycle comprising 2 or 3 
heteroatoms independently selected from the group consisting of N, S and 0, wherein said 
20 5- or 6-membered aromatic heterocycle is optionally substituted with 1, 2 or 3 substituents, 
each substituent being independently selected from the group consisting of C1-3alkyl and C1 .  
3alkyl substituted with 1, 2 or 3 halogens. The invention also provides pharmaceutical 
compositions comprising a compound of formula (1), and the use of compounds of formula 
(1) as medicaments, in particular in the treatment of cancer.  
25
Patent WO-2006105622-A1 (WO)
Title: Novel supports, in particular for immunodetection of molecules of interest
Inventor: HEINEN ERNST
IPC: B29C59/14
Filed: 2006-04-04
Abstract: The invention concerns supports or receptacles for solubilized or suspended biological entities whereof the walls are made of plastics surface-treated by an electromagnetic plasma followed by a polymer deposition. It can be in the form of tubes or multiple-well plates. It provides among other things the possibility of storing, transferring and performing reactions in the context of microassays of biological entities, more particularly the prion protein, with enhanced sensitivity.
Patent WO-2016041034-A1 (WO)
Title: Method for freezing/cryopreserving epididymal semen and/or postmortem freezing
Inventor: PEREZ EDUARDO GUALTIERI DE ANDRADE
IPC: A01N1/02
Filed: 2015-09-14
Abstract: The present invention patent relates to a method for freezing/cryopreserving epididymal semen and/or postmortem freezing, for semen from the head and tail of epididymides of cattle, buffalo, dogs, goats, horses, sheep and pigs, pertaining to the technical fields of biotechnology applied to animal breeding and cryobiology. The importance of the present invention relates to the possibility of freezing semen samples after the death of breeders of high zootechnical value, in order to conserve genetic material, which can become part of one of the largest germplasm banks in the world, the Brazilian germplasm bank. The present invention provides a method for freezing/cryopreserving epididymal semen and/or postmortem freezing, allowing semen samples to be frozen after the death of breeders of high zootechnical value such that the genetic material from the head and tail of epididymides of cattle, buffalo, dogs, goats, horses, sheep and pigs, can be conserved by means of eight main steps: 1 - stowage of the testicles; 2 - washing and drying the testicles; 3 - extraction of spermatozoa; 4 - laboratory analysis; 5 - dilution; 6 - cryopreservation; 7 - freezing; and 8 - storage.